Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
ERNA holding history
Ernexa Therapeutics Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ERNA overviewAll 13F holders of ERNAFull Q4 2025 holdings
- Shares (Q4 2025)
- 35,922
- Value
- $43.1K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 35,922 | $43.1K | <0.1% | +24,775+222.3% | Added | Holders |
| Q3 2025 | 11,147 | $12.2K | <0.1% | +11,147 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −2,546−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q1 2025 | 38,190 | $6.80K | <0.1% | +12,091+46.3% | Added | Holders |
| Q4 2024 | 26,099 | $7.67K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 26,099 | $27.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 26,099 | $47.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 26,099 | $62.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 26,099 | $46.8K | <0.1% | +1,201+4.8% | Added | Holders |
| Q3 2023 | 24,898 | $54.3K | <0.1% | +5,830+30.6% | Added | Holders |
| Q2 2023 | 19,068 | $43.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 19,068 | $64.8K | <0.1% | −10,000−34.4% | Reduced | Holders |
| Q4 2022 | 29,068 | $93.6K | <0.1% | +29,068 | New | Holders |